|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1810 News |
|
| «12...1112131415161718192021...3132» |
- Trial primary completion date: Effects of Curcumin on Vascular Reactivity (clinicaltrials.gov) - Jul 8, 2014
P1/2, N=21, Completed, Sponsor: University Hospital, Clermont-Ferrand
Trial primary completion date: Aug 2012 --> Apr 2012
- Trial completion, Trial primary completion date: Effects of Curcumin on Vascular Reactivity (clinicaltrials.gov) - Jul 8, 2014
P1/2, N=21, Completed, Sponsor: University Hospital, Clermont-Ferrand
Trial primary completion date: Aug 2012 --> Apr 2012 Recruiting --> Completed | Trial primary completion date: Aug 2012 --> Apr 2012
- Chantix (varenicline) / Pfizer
Trial primary completion date: Effectiveness of Varenicline: Testing Individual Differences (clinicaltrials.gov) - Jul 4, 2014
P4, N=216, Active, not recruiting, Sponsor: The Mind Research Network
Recruiting --> Completed | Trial primary completion date: Aug 2012 --> Apr 2012 Trial primary completion date: May 2014 --> Mar 2016
- Chantix (varenicline) / Pfizer
Enrollment closed, Trial primary completion date: Effectiveness of Varenicline: Testing Individual Differences (clinicaltrials.gov) - Jul 4, 2014
P4, N=216, Active, not recruiting, Sponsor: The Mind Research Network
Trial primary completion date: May 2014 --> Mar 2016 Recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Mar 2016
- bupropion sustained-release / Generic mfg.
Enrollment open: QUIT4EVER: Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD (clinicaltrials.gov) - Jul 2, 2014
P=N/A, N=30, Recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting | Trial primary completion date: May 2014 --> Mar 2016 Not yet recruiting --> Recruiting
- galantamine extended release / Generic mfg.
Trial completion: Effect of Galantamine on Smoking Abstinence (clinicaltrials.gov) - Jul 2, 2014
P2, N=13, Completed, Sponsor: University of Pennsylvania
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial primary completion date: Nicotine Receptor Levels and Smoking Cessation (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=30, Active, not recruiting, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed Trial primary completion date: Dec 2013 --> Sep 2014
- New P1 trial: Effects Of Passive Smoking On The Respiratory System Mechanics Of Healthy Non-Smokers In Different Body Positions (clinicaltrials.gov) - Jun 27, 2014
P1, N=20, Completed, Sponsor: Hellenic Anticancer Society
- Enrollment closed, Trial primary completion date: Nicotine Receptor Levels and Smoking Cessation (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=30, Active, not recruiting, Sponsor: University of Pennsylvania
Trial primary completion date: Dec 2013 --> Sep 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Sep 2014
- Trial completion: Effects Of Passive Smoking On The Respiratory System Mechanics Of Healthy Non-Smokers In Different Body Positions (clinicaltrials.gov) - Jun 27, 2014
P1, N=20, Completed, Sponsor: Hellenic Anticancer Society
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Sep 2014 Not yet recruiting --> Completed
- Trial completion: Promoting Smoking Cessation in the Community Via Quit to Win Contest 2013 (clinicaltrials.gov) - Jun 27, 2014
P=N/A, N=1143, Completed, Sponsor: The University of Hong Kong
Not yet recruiting --> Completed Recruiting --> Completed
- ||| HEOR: Effect of Spiriva (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=10821, Completed, Sponsor: Boehringer Ingelheim
- ||| Trial completion, HEOR: Effect of Spiriva (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=10821, Completed, Sponsor: Boehringer Ingelheim
Recruiting --> Completed Not yet recruiting --> Completed
- Trial completion: Simplified Cardiovascular Management Study (clinicaltrials.gov) - Jun 26, 2014
P=N/A, N=2086, Completed, Sponsor: The George Institute for Global Health, China
Not yet recruiting --> Completed Recruiting --> Completed
- || PF-05402536 / Pfizer
Trial primary completion date: A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers. (clinicaltrials.gov) - Jun 26, 2014
P1, N=200, Recruiting, Sponsor: Pfizer
Recruiting --> Completed Trial primary completion date: Apr 2014 --> May 2014
- Trial primary completion date: Early Smoking Reduction or Cessation by Means of no Nicotine Electronic Cigarette Added to Standard Counselling. (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=126, Recruiting, Sponsor: European Institute of Oncology
Trial primary completion date: Apr 2014 --> May 2014 Trial primary completion date: Dec 2012 --> Dec 2014
- FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial initiation date: Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=100, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Trial primary completion date: Dec 2012 --> Dec 2014 Initiation date: Jan 2014 --> Jun 2014
- FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Enrollment change: Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=100, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Initiation date: Jan 2014 --> Jun 2014 N=80 --> 100
- FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Enrollment open, Enrollment change, Trial initiation date: Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=100, Recruiting, Sponsor: University of North Carolina, Chapel Hill
N=80 --> 100 Not yet recruiting --> Recruiting | N=80 --> 100 | Initiation date: Jan 2014 --> Jun 2014
- Enrollment closed: Enhancing a High School Based Smoking Cessation Program (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=240, Active, not recruiting, Sponsor: Yale University
Not yet recruiting --> Recruiting | N=80 --> 100 | Initiation date: Jan 2014 --> Jun 2014 Recruiting --> Active, not recruiting
- Trial primary completion date: Computer-Assisted Counseling in Helping African American Smokers Stop Smoking (clinicaltrials.gov) - Jun 18, 2014
P=N/A, N=500, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Active, not recruiting Trial primary completion date: Apr 2015 --> Apr 2016
- Trial primary completion date: Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (clinicaltrials.gov) - Jun 18, 2014
P=N/A, N=650, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Apr 2015 --> Apr 2016 Trial primary completion date: Nov 2015 --> Nov 2016
- New P2 trial: Mindfulness Training for Smokers Online Feasibility Study (clinicaltrials.gov) - Jun 17, 2014
P2, N=26, Completed, Sponsor: University of Wisconsin, Madison
- || Chantix (varenicline) / Pfizer
Trial primary completion date: ConNic5: Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers (clinicaltrials.gov) - Jun 13, 2014
P2, N=280, Recruiting, Sponsor: Duke University
Trial primary completion date: Nov 2015 --> Nov 2016 Trial primary completion date: Jun 2014 --> Dec 2014
- Trial primary completion date: Smoking Cessation for Smokers With Sleep Problems (clinicaltrials.gov) - Jun 13, 2014
P0, N=19, Completed, Sponsor: Yale University
Trial primary completion date: Jun 2014 --> Dec 2014 Trial primary completion date: Dec 2012 --> Mar 2012
- || Enrollment change: Nicotine Patch - Bioequivalence Study (clinicaltrials.gov) - Jun 13, 2014
P1, N=74, Completed, Sponsor: Pierre Fabre Medicament
Trial primary completion date: Dec 2012 --> Mar 2012 N=42 --> 74
- Enrollment change: Smoking Cessation for Smokers With Sleep Problems (clinicaltrials.gov) - Jun 13, 2014
P0, N=19, Completed, Sponsor: Yale University
N=42 --> 74 N=30 --> 19
- Enrollment open: Smoking, Stress & Allopregnanolone Response (clinicaltrials.gov) - Jun 13, 2014
P=N/A, N=60, Recruiting, Sponsor: University of Minnesota - Clinical and Translational Science Institute
N=30 --> 19 Not yet recruiting --> Recruiting
- ||| Trial completion: Nicotine Patch - Bioequivalence Study (clinicaltrials.gov) - Jun 13, 2014
P1, N=74, Completed, Sponsor: Pierre Fabre Medicament
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Smoking Cessation for Smokers With Sleep Problems (clinicaltrials.gov) - Jun 13, 2014
P0, N=19, Completed, Sponsor: Yale University
Recruiting --> Completed Active, not recruiting --> Completed | N=30 --> 19 | Trial primary completion date: Dec 2012 --> Mar 2012
- | Chantix (varenicline) / Pfizer
Enrollment change: Varenicline (Champix (clinicaltrials.gov) - Jun 12, 2014
P4, N=20, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed | N=30 --> 19 | Trial primary completion date: Dec 2012 --> Mar 2012 N=100 --> 20
- | Chantix (varenicline) / Pfizer
Trial completion: Varenicline (Champix (clinicaltrials.gov) - Jun 12, 2014
P4, N=20, Completed, Sponsor: Pfizer
N=100 --> 20 Enrolling by invitation --> Completed
- Chantix (varenicline) / Pfizer
Enrollment open, Real-world evidence, Real-world effectiveness, Real-world: The MATCH (Medication Aids for Tobacco Cessation and Health) Study (clinicaltrials.gov) - Jun 5, 2014
P=N/A, N=1500, Recruiting, Sponsor: Centre for Addiction and Mental Health
Enrolling by invitation --> Completed Not yet recruiting --> Recruiting
- ||| Belviq (lorcaserin) / Eisai
Enrollment closed: A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation (clinicaltrials.gov) - Jun 3, 2014
P2, N=600, Active, not recruiting, Sponsor: Arena Pharmaceuticals
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Trial completion: Motivation: Identifying Treatments to Motivate Smokers to Quit (clinicaltrials.gov) - Jun 2, 2014
P4, N=517, Completed, Sponsor: University of Wisconsin, Madison
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change: Effects of Quitting Study A Test of Pre-clinical Findings (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=105, Recruiting, Sponsor: University of Vermont
Active, not recruiting --> Completed N=210 --> 105
- Trial completion: Arterial Remodeling in Smokers (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=50, Completed, Sponsor: Klinik f
N=210 --> 105 Recruiting --> Completed
- Trial completion: Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET (clinicaltrials.gov) - Jun 2, 2014
P1/2, N=6, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed Recruiting --> Completed
- Biomarker, Trial primary completion date: Biomarkers of Molecular Risk in Smokers (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=40, Active, not recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Completed Trial primary completion date: Feb 2014 --> Feb 2015
- Trial primary completion date: NDS: Nicotine Delivery Systems: Research & Treatment (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=25, Terminated, Sponsor: Department of Veterans Affairs
Trial primary completion date: Feb 2014 --> Feb 2015 Trial primary completion date: Sep 2011 --> Sep 2009
- Trial termination: NDS: Nicotine Delivery Systems: Research & Treatment (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=25, Terminated, Sponsor: Department of Veterans Affairs
Trial primary completion date: Sep 2011 --> Sep 2009 Completed --> Terminated; Common comorbidities of Veterans precluded sufficient recruitment and enrollment.
- Clinical: Progressive Muscle Relaxation and Cigarette Craving (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=34, Completed, Sponsor: Chulalongkorn University
- Trial primary completion date: RCT-OMSC-PC: Integrating the "Ottawa Model" for Smoking Cessation Into Primary Care Practice (clinicaltrials.gov) - May 28, 2014
P=N/A, N=20, Recruiting, Sponsor: University of Ottawa Heart Institute
Completed --> Terminated; Common comorbidities of Veterans precluded sufficient recruitment and enrollment. Trial primary completion date: Sep 2014 --> Dec 2014
- || New P3 trial: Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers (clinicaltrials.gov) - May 26, 2014
P3, N=398, Recruiting, Sponsor: University of Kansas
- Trial primary completion date: A Randomized Controlled Trial to Test the Effect of a Smartphone Quit Smoking Intervention on Young Adult Smokers (clinicaltrials.gov) - May 25, 2014
P=N/A, N=1354, Recruiting, Sponsor: University of Waterloo
Trial primary completion date: Sep 2014 --> Dec 2014 Trial primary completion date: Aug 2014 --> May 2015
- Trial completion date: A Randomized Controlled Trial to Test the Effect of a Smartphone Quit Smoking Intervention on Young Adult Smokers (clinicaltrials.gov) - May 25, 2014
P=N/A, N=1354, Recruiting, Sponsor: University of Waterloo
Trial primary completion date: Aug 2014 --> May 2015 Trial completion date: Jan 2015 --> Jan 2016
- Enrollment open: A Randomized Controlled Trial to Test the Effect of a Smartphone Quit Smoking Intervention on Young Adult Smokers (clinicaltrials.gov) - May 25, 2014
P=N/A, N=1354, Recruiting, Sponsor: University of Waterloo
Trial completion date: Jan 2015 --> Jan 2016 Not yet recruiting --> Recruiting
- Chantix (varenicline) / Pfizer
Real-world evidence, Real-world effectiveness, Real-world: The MATCH (Medication Aids for Tobacco Cessation and Health) Study (clinicaltrials.gov) - May 22, 2014
P=N/A, N=1500, Not yet recruiting, Sponsor: Centre for Addiction and Mental Health
- New P4 trial: Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients (clinicaltrials.gov) - May 22, 2014
P4, N=20, Not yet recruiting, Sponsor: University of Cincinnati
- Trial primary completion date: Concurrent PET D2/D3 Receptor Imaging and fMRI Smoking Cue Reactivity in Smokers (clinicaltrials.gov) - May 21, 2014
P1, N=0, Withdrawn, Sponsor: Mclean Hospital
Not yet recruiting --> Recruiting Trial primary completion date: Mar 2014 --> May 2014